[KROS] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[KROS] Keros Therapeutics, Inc.
Announcement Date
04-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -10.16%
YoY- -35.36%
Quarter Report
KROS's Result
KROS's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 143 8 0 0 0 0 100 26.84%
PBT -40,243 -39,440 -37,505 -35,804 -29,718 -23,509 -27,266 29.54%
Tax 3,812 -210 3,832 -3,065 2 -4,467 -3,462 -
NP -40,243 -39,440 -37,505 -32,739 -29,720 -19,042 -23,804 41.77%
Tax Rate - - - - - - - -
Total Cost 40,386 39,448 37,505 32,739 29,720 19,042 23,904 41.71%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -28,141.96 -493,000.00 0.00 0.00 0.00 0.00 -23,804.00 11.77%
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -1.34 -1.33 -1.27 -1.15 -1.09 -0.75 -0.99 22.29%
EPS Diluted -1.34 -1.33 -1.27 -1.15 -1.09 -0.75 -0.99 22.29%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.